Welcome to our dedicated page for Huntington Ingalls Inds SEC filings (Ticker: HII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Huntington Ingalls Industries, Inc. (HII) provides access to the company’s official disclosures as a global, all-domain defense provider and the nation’s largest military shipbuilder. Through these documents, investors can review how HII reports on its shipbuilding programs, Mission Technologies activities, contracts and overall financial condition.
Key filings include annual reports on Form 10-K, where HII typically outlines its major business segments, risk factors related to defense contracting and shipbuilding, and long-term program commitments, and quarterly reports on Form 10-Q, which update results of operations and cash flows. Current reports on Form 8-K capture material events, such as the company’s announcements of quarterly financial results and changes in board composition, as illustrated by recent 8-K filings describing earnings releases and the election of a new director.
Users can also examine proxy statements for information on board structure and governance, and Form 4 insider transaction reports that detail purchases and sales of HII equity by directors, officers and other insiders. These filings help investors assess governance practices and insider alignment with shareholders.
On Stock Titan, HII filings are supplemented with AI-powered summaries that explain the key points of lengthy documents, highlight segment-level themes and clarify technical language common in defense and shipbuilding disclosures. Real-time updates from the SEC’s EDGAR system ensure that new 10-K, 10-Q, 8-K and Form 4 filings appear quickly, while AI-generated highlights make it easier to understand how new contracts, program milestones, governance changes and financial updates are reflected in HII’s regulatory record.
Director Victoria D. Harker of Huntington Ingalls Industries (HII) filed a Form 4 for an open-market sale executed on 08/05/2025. The filing shows the sale of 1,000 common shares at a weighted-average price of $268.63 (high $269.24 / low $268.19). After the transaction the director directly owns 3,379 common shares.
The report also lists 7,680.59 stock unit account (SUA) shares still beneficially owned. No derivative security transactions, purchases, or option exercises were disclosed.
Aside from this modest reduction in direct holdings, the filing contains no additional corporate events or guidance changes.
Huntington Ingalls Industries (HII) – Form 4 insider transaction
Executive Vice President & President of HII Mission Technologies, Edgar A. Green III, reported an open-market sale of 4,206.547 common shares on 08/04/2025 at a weighted-average price of $265.64 (price range $266.12-$266.55). Gross proceeds are roughly $1.12 million.
After the sale, Green directly owns 7,049.64 shares and indirectly holds 2,065.6 shares through the company 401(k) plan. No derivative transactions were reported, and no Rule 10b5-1 trading plan box was checked.
The disposition represents an estimated ≈37% reduction in the insider’s direct equity stake (11,256 shares before the sale versus 7,050 shares after). Although management continues to own stock, investors often view sizable discretionary sales by key officers as a modest negative signal absent offsetting information such as option exercise-related taxes or a pre-arranged trading plan.
Huntington Ingalls Industries, Inc. (HII) filed a Form 144 indicating an insider’s intent to sell up to 1,000 common shares through Fidelity Brokerage Services on the NYSE around 08/05/2025. The shares have an aggregate market value of $268,627.56, based on the filing’s reference price. With 39,240,631 shares outstanding, the proposed sale represents roughly 0.003 % of HII’s equity—an immaterial amount in terms of float and daily trading volume.
The securities were originally acquired via a series of restricted-stock vestings between 2017-2018. No sales have been made by the filer in the past three months, and the signer certifies no undisclosed adverse information. The Form 144 is a routine disclosure, suggesting personal portfolio management rather than a strategic shift by the company.